Quarterly Dividend Increase of 8%
LANGLEY,
BC, Nov. 8, 2022 /CNW/ - Hardwoods
Distribution Inc. ("HDI" or the "Company") today announced
financial results for the three and nine months ended
September 30, 2022 and an 8% increase to the quarterly
dividend. HDI is one of North
America's largest suppliers of specialty building products
to fabricators, home centers and professionals dealers servicing
the repair and remodel, residential, and commercial construction
end-markets. The Company currently operates a network of 86
facilities in the United States
and Canada. All amounts are shown
in United States dollars ("U.S. $"
or "$"), unless otherwise noted.
Third Quarter Highlights
- Third quarter sales grew 39.9% to $659.7
million, a year-over-year increase of $188.0 million. Achieved organic sales growth of
10.4% and acquisition-based sales growth of 29.9%.
- Gross profit climbed 19.6%, or $22.8
million, to $139.0 million,
with gross profit margin percentage of 21.1%, as compared to 24.6%
in the same period last year.
- Profit per share was $1.28;
adjusted profit per share was $1.32
per share
- Adjusted EBITDA climbed 3.4% to $66.0
million, from $63.8 million
during the same period in 2021.
- Cash flow from operating activities, before changes in working
capital, was $1.84 per share.
- In Canadian dollars, sales for the third quarter were
C$856.7 million, adjusted profit per
share was C$1.71, and Adjusted EBITDA
was C$85.7 million.
- The board of directors today approved an 8% increase to the
quarterly dividend to C$0.13 per
share, from C$0.12 per share
previously, which equates to C$0.52
per share on an annual basis. The increase is effective with the
quarterly dividend payable on January 27,
2023 to shareholders of record as at January 16, 2023.
"We achieved another quarter of excellent financial and
operating performance as our growth strategy, proven business model
and disciplined operating management combined to deliver very
strong third quarter results," said Rob
Brown, HDI's President and CEO. "Market conditions remained
supportive of our business, with increased product prices resulting
in strong organic sales growth of over 10% as compared to the same
quarter last year. Combined with acquisition-based growth, our
total sales grew nearly 40% year-over-year."
"Our results reflect the positive impact of our new Mid-Am and
Novo operations, acquired in Q3 2021 and Q1 2022, respectively.
These businesses have brought us important scale, access to new
geographies, and a strong presence in the U.S. Pro Dealer and home
center channels, and combined, are expected to deliver over
$1 billion in pro forma sales in
2022."
"Importantly, our performance has enabled us to increase our
returns to investors. In the first nine months of 2022, we returned
almost $25 million to shareholders
through a combination of dividends and share repurchases, up from
$5.0 million in the same period last
year. With today's announcement of an 8% increase to our quarterly
dividend, we are providing further returns to our shareholders
going forward."
"Going forward, we will continue to closely monitor economic
conditions and the impacts that price inflation, rising interest
rates, and other factors can have on our business. We benefit from
a highly experienced team with a long track record of successfully
managing our operations and controlling costs through changing
markets. We believe our business has the resilience to manage
through these cycles, and we anticipate a multi-year runway for
growth and value creation as we benefit from our leading market
position and the long-term positive fundamentals underpinning the
North American building products market," said Mr. Brown.
Outlook
In the nearer term we anticipate that rising
inflation and recent interest rate hikes will have a negative
impact on economic activity, and this may result in a moderation of
demand for our products. As we have demonstrated in previous
cycles, we will take all necessary actions required to effectively
manage our business and cash flows. We maintain a strong balance
sheet which provides financial stability through periods of
changing market conditions. Our business model also converts a high
proportion of EBITDA to operating cash flow before changes in
working capital, and during periods of reduced activity our
investment in working capital has historically decreased, resulting
in an additional source of cash.
Over the long term we expect demand for our products
to remain robust, supported by strong fundamentals in our end
markets. We continue to see a multi-year runway for growth in the
repair and remodel, residential, and commercial end-markets that we
participate in.
Outlook for our end-markets
The repair and remodel market (~40% of sales) is expected
to remain strong, albeit with a tempering of the higher-than-normal
growth rates experienced in the past year. The Joint Center for
Housing Studies of Harvard University
anticipates a growth rate of 6.5% for the U.S. repair and remodel
market by the third quarter of 2023. Overall, the market remains
well supported by record levels of home equity in the U.S. and a
median home age of over 40 years. Disaster repairs and mitigation
projects following Hurricane Ian are also expected to support the
home remodeling market in the coming year.
In the residential construction market (~40% of sales),
new building starts have moderated as affordability headwinds weigh
on consumers, but remain at historically healthy levels. Given that
housing completions have not kept pace with starts over the past
quarters, we also continue to see an elongated demand curve for our
products, which are typically installed during the finishing stages
of home construction. Over the longer term, leading indicators for
the residential construction market remain highly favorable.
Housing starts have meaningfully lagged population growth this past
decade, and it is estimated that the U.S. has a housing supply
deficit of over 3.5 million units. This supply deficit, combined
with positive demographic factors, is expected to underpin
long-term demand for new housing.
The demand outlook for U.S. commercial markets (~15% of
sales) is mixed, with some sectors showing strength and others
recovering at a slower pace. Commercial market participation is
highly diverse for HDI and includes construction activity in
healthcare, education, public buildings, hospitality, office,
retail facilities and recreational vehicles. We expect certain of
these commercial end markets will perform better than others, with
the broad nature of our participation reducing the impact of
dynamics in any one geography or end market.
Q3 2022 Investor Call
HDI will hold an investor call on Wednesday November 9, 2022 at 8:00 am Pacific (11:00
am Eastern). Participants should dial 1-888-254-3590 or
(647) 484-0475 (GTA) at least five minutes before the call begins.
A replay will be available through November
16, 2022 by calling toll free 1-888-390-0541 or (416)
764-8677 (GTA), followed by passcode 852499.
Summary of Results
|
|
|
|
|
|
|
|
|
|
Three
months
|
|
Three
months
|
|
Nine
months
|
|
Nine
months
|
|
|
ended
September 30
|
|
ended
September 30
|
|
ended
September 30
|
|
ended
September 30
|
|
|
2022
|
|
2021
|
|
2022
|
|
2021
|
|
Total sales
|
$
659,685
|
|
$
471,673
|
|
$
2,004,834
|
|
$
1,100,846
|
|
Sales in the
US
|
610,360
|
|
426,738
|
|
1,847,481
|
|
970,393
|
|
Sales in Canada
(C$)
|
64,496
|
|
56,660
|
|
201,853
|
|
163,535
|
|
Gross profit
|
138,964
|
|
116,190
|
|
440,575
|
|
250,020
|
|
Gross profit
%
|
21.1 %
|
|
24.6 %
|
|
22.0 %
|
|
22.7 %
|
|
Operating
expenses
|
(90,902)
|
|
(67,303)
|
|
(268,549)
|
|
(148,160)
|
|
Profit from operating
activities
|
$
48,062
|
|
$
48,887
|
|
$
172,026
|
|
$
101,860
|
|
Add: Depreciation and
amortization
|
16,830
|
|
11,748
|
|
48,523
|
|
24,063
|
|
Earnings before
interest, taxes, depreciation and
|
|
|
|
|
|
|
|
|
amortization
("EBITDA")
|
$
64,892
|
|
$
60,635
|
|
$
220,549
|
|
$
125,923
|
|
EBITDA as a % of
revenue
|
9.8 %
|
|
12.9 %
|
|
11.0 %
|
|
11.4 %
|
|
Add
(deduct):
|
|
|
|
|
|
|
|
|
Depreciation and
amortization
|
(16,830)
|
|
(11,748)
|
|
(48,523)
|
|
(24,063)
|
|
Net finance income
(expense)
|
(8,926)
|
|
(3,803)
|
|
(20,097)
|
|
(6,664)
|
|
Income tax
expense
|
(9,260)
|
|
(11,387)
|
|
(36,650)
|
|
(24,196)
|
|
Profit for the
period
|
$
29,876
|
|
$
33,696
|
|
$
115,279
|
|
$
71,000
|
|
Basic profit per
share
|
$
1.28
|
|
$
1.58
|
|
$
4.89
|
|
$3.34
|
|
Diluted profit per
share
|
$
1.27
|
|
$
1.56
|
|
$
4.85
|
|
$3.29
|
|
Average Canadian dollar
exchange rate for one US dollar
|
$
0.77
|
|
$
0.79
|
|
$
0.78
|
|
0.799
|
|
Analysis of Specific
Items Affecting Comparability (in thousands of Canadian
dollars)
|
|
Three
months
|
|
Three
months
|
|
Nine
months
|
|
Nine
months
|
|
|
ended
September 30
|
|
ended
September 30
|
|
ended
September 30
|
|
ended
September 30
|
|
|
2022
|
|
2021
|
|
2022
|
|
2021
|
|
Earnings before
interest, taxes, depreciation and
|
|
|
|
|
|
|
|
|
amortization
("EBITDA"), per table above
|
$
64,892
|
|
$
60,635
|
|
$
220,549
|
|
$
125,923
|
|
Non-cash LTIP
expense
|
1,075
|
|
1,288
|
|
2,927
|
|
3,576
|
|
Transaction
expenses
|
—
|
|
1,903
|
|
892
|
|
4,071
|
|
Adjusted
EBITDA
|
$
65,967
|
|
$
63,826
|
|
$
224,368
|
|
$
133,570
|
|
Adjusted EBITDA as a
% of revenue
|
10.0 %
|
|
13.5 %
|
|
11.2 %
|
|
12.1 %
|
|
|
|
|
|
|
|
|
|
|
Profit for the period,
as reported
|
$
29,876
|
|
$
33,696
|
|
$
115,279
|
|
$
71,000
|
|
Adjustments, net of
tax
|
957
|
|
2,579
|
|
3,256
|
|
6,310
|
|
Adjusted profit for the
period
|
$
30,833
|
|
$
36,275
|
|
$
118,535
|
|
$
77,310
|
|
|
|
|
|
|
|
|
|
|
Basic profit per share,
as reported
|
$
1.28
|
|
$
1.58
|
|
$
4.89
|
|
$
3.34
|
|
Net impact of above
items per share
|
0.04
|
|
0.12
|
|
0.14
|
|
0.30
|
|
Adjusted basic profit
per share
|
$
1.32
|
|
$
1.70
|
|
$
5.03
|
|
$
3.64
|
|
|
|
|
|
|
|
|
|
|
Diluted profit per
share, as reported
|
$
1.27
|
|
$
1.56
|
|
$
4.85
|
|
$
3.29
|
|
Net impact of above
items per share
|
0.04
|
|
0.12
|
|
0.14
|
|
0.29
|
|
Adjusted diluted profit
per share
|
$
1.31
|
|
$
1.68
|
|
$
4.99
|
|
$
3.58
|
|
Results from Operations - Three Months Ended September 30,
2022
For the three months ended September 30, 2022, consolidated
sales grew to $659.7 million,
an increase of $188.0 million, or
39.9%, from $471.7 million in the
same period in 2021. Organic sales growth accounted for
$48.9 million of this gain,
representing a 10.4% increase in consolidated sales. Acquired
businesses (the "Acquired Businesses") contributed an additional
$140.9 million of the sales growth,
and included Novo's July 2022 revenue
of $58.8 million and Mid-Am's Q3 2022
revenue of $82.0 million. Combined,
additional revenue from Acquired Businesses represented a 29.9%
increase in total sales. These gains were partially offset by
$1.8 million of unfavorable foreign
exchange impact.
Third quarter sales from our U.S. operations grew to
$610.4 million, an increase of
$183.6 million, or 43.0%, from
$426.7 million in the same period in
2021. Organic sales growth accounted for $42.7 million of this improvement, representing a
10.0% increase in U.S. sales. The strong organic growth was
primarily supported by increased product prices, partially offset
by a modest decrease in volumes. Incremental revenue from Acquired
Businesses contributed an additional $140.9
million to third quarter U.S. sales growth, representing a
33% increase in U.S. sales.
In Canada, third quarter sales
increased by C$7.8 million, or 13.8%,
compared to the same period in 2021. The Canadian sales growth was
entirely organic and reflects higher product prices year-over-year,
partially offset by a modest decrease in volumes.
Gross profit for the third quarter grew 19.6% to $139.0 million, from $116.2 million in the same quarter last year.
This $22.8 million improvement
reflects the significant sales growth, partially offset by a lower
gross margin percentage. At 21.1%, our gross margin
percentage did not match the unusually high 24.6% achieved in Q3
2021 when favorable market dynamics, including strong demand and
tight supply, resulted in a rapid increase in product prices as
compared to the cost of inventory.
For the three months ended September 30, 2022, operating
expenses increased by $23.6 million
to $90.9 million, from $67.3 million in Q3 2021. As a percentage of
sales, operating expenses were lower at 13.8%, as compared to 14.3%
in the same period last year.
The $23.6 million increase in
operating expenses includes $15.8
million related to incremental operating expenses from our
Acquired Businesses, $6.4 million to
support organic growth, and $3.3
million of amortization on intangible assets acquired in
connection with the Novo and Mid-Am acquisitions. These increases
were partially offset by $1.9 million
of Novo-related transaction costs incurred in Q3 2021, which did
not repeat in 2022.
For the three months ended September 30, 2022, depreciation
and amortization increased to $16.8
million, from $11.7 million in
Q3 2021. This $5.1 million increase
primarily relates to the acquisition and operations of the Novo and
Mid-Am businesses and is comprised of $3.3
million of amortization on acquired intangible assets and
$1.8 million from depreciation
related to operations.
For the three months ended September 30, 2022, net finance
expense increased to $8.9 million,
from $3.8 million last year. This
increase was primarily driven by interest costs on the additional
bank indebtedness used to finance the acquisitions of Novo and
Mid-Am, as well as higher interest rates.
For the three months ended September 30, 2022, income tax
expense decreased to $9.3 million,
from $11.4 million last year,
primarily reflecting lower taxable income.
Third quarter Adjusted EBITDA climbed 3.4% to $66.0 million, from $63.8
million during the same period in 2021. The $2.2 million improvement was driven primarily by
the $22.8 million increase in gross
profit, partially offset by the $20.6
million increase in operating expenses (before changes in
depreciation and amortization, non-cash LTIP expense, and
transaction expenses).
Profit for the third quarter decreased by 11.3% to $29.9 million, from $33.7
million in Q3 2021. The $3.8
million change primarily reflects a $5.1 million increase in depreciation and
amortization, and the $5.0 million
increase in net finance expense, partially offset by the
$4.3 million increase in EBITDA and
$2.1 million lower income tax
expense.
For the three months ended September 30, 2022, we generated
basic profit per share of $1.28, as
compared to $1.58 in Q3 2021, a
decrease of 19.0%. Adjusted profit was $30.8
million, as compared to $36.3
million in Q3 2021, a decrease of 15.0% and Adjusted
diluted profit per share was $1.31,
as compared to $1.68, a decrease of
22.0%.
Results from Operations - Nine Months Ended
September 30, 2022
For the nine months ended September 30, 2022, consolidated
sales climbed 82.1% to $2.0 billion,
an increase of $904.0 million from
$1.1 billion in the same period in
2021. Organic sales growth accounted for $241.9 million of this gain, representing a 22.0%
increase in consolidated sales. Acquisition-based revenue growth,
including Novo's January to July 2022
revenue of $453.5 million, and
Mid-Am's year-to-date revenue of $219.0
million, increased consolidated revenue by a combined
61.1% year-over-year. These gains were partially offset by the
first quarter 2021 divestiture of our HMI business, which resulted
in $6.4 million of sales not
recurring in the current period. Foreign exchange fluctuations in
the Canadian dollar also had an unfavorable $4.0 million impact on sales results.
First nine months sales from our U.S. operations grew 90.4% to
$1.8 billion, a year-over-year
increase of $877.1 million, from
$970.4 million in the same period
last year. Organic sales growth accounted for $204.6 million of this improvement, representing
a 21.1% year-over-year increase in U.S. sales. The strong organic
growth was primarily supported by robust market demand,
particularly during the first half of the year, which in turn
contributed to improved product prices. The Novo and Mid-Am
operations contributed an additional $672.5
million to year-to-date U.S. sales growth, representing a
69.3% increase in U.S. sales.
In Canada, sales for the first
nine months increased by C$38.3
million, or 23.4%, compared to the same period in 2021. The
Canadian sales growth was entirely organic and reflects the strong
market demand particularly in the first half of the year, which
resulted in improved market prices for our products
year-over-year.
Gross profit for the first nine months grew 76.2% to
$440.6 million, from $250.0 million in the same period last year. This
$190.6 million improvement reflects
our significant organic and acquisition-based sales growth. At
22.0%, our gross profit margin was slightly lower than the 22.7% we
achieved in the same period last year. The gross margin percentage
in 2021 was temporarily elevated due to favorable market dynamics,
including strong demand and tight supply.
For the nine months ended September 30, 2022, operating
expenses were $268.5 million as
compared to $148.2 million in the
same period last year, an increase of $120.4
million. As a percentage of sales, operating expenses were
well controlled at 13.4%, similar to 13.5% in the first nine months
of last year.
The $120.4 million increase in
operating expenses includes $90.3
million related to operation of our Acquired Businesses,
$21.0 million to support organic
growth, and $12.3 million of
amortization on intangible assets acquired in connection with the
Novo and Mid-Am acquisitions. These increases were partially offset
by $3.2 million of Novo-related
transaction costs incurred in the first nine months of 2021, which
did not repeat in the 2022 period.
For the nine months ended September 30, 2022, depreciation
and amortization increased by $24.5
million to $48.5 million, from
$24.1 million in the prior-year
period. This increase mainly relates to the acquisition and
operations of the Novo and Mid-Am businesses and is primarily
comprised of $12.3 million of
amortization on acquired intangible assets, and $12.1 million from depreciation related to
operations.
For the nine months ended September 30, 2022, net finance
expense increased to $20.1 million,
from $6.7 million last year. The
increase was primarily driven by interest on issuance of new bank
indebtedness used to finance the acquisitions of Novo and Mid-Am,
combined with higher interest rates.
For the nine months ended September 30, 2022, income tax
expense increased to $36.7 million,
from $24.2 million last year,
primarily driven by a higher taxable income.
Year-to-date Adjusted EBITDA climbed 68.0% to $224.4 million, from $133.6 million in the same period of 2021. This
$90.8 million improvement reflects
the $190.6 million increase in gross
profit, partially offset by the $99.8
million increase in operating expenses (before changes in
depreciation and amortization, non-cash LTIP expense, and
transaction expenses).
Profit for the first nine months grew 62.4% to $115.3 million, from $71.0
million in the first nine months of 2021. The $44.3 million profit improvement primarily
reflects the $94.6 million increase
in EBITDA, partially offset by a $24.5
million increase in depreciation and amortization, the
$12.5 million increase in income tax
expense, and the $13.4 million
increase in net finance expense.
For the nine months ended September 30, 2022, basic profit
per share climbed 46.4% to $4.89,
from $3.34 in the same period last
year. Adjusted profit increased 53.3% to $118.5 million, from $77.3
million in the first nine months of 2021 and Adjusted
diluted profit per share grew 39.4% to $4.99, from $3.58
in the same period last year.
About HDI
HDI is one of North America's
largest suppliers of specialty building products to fabricators,
home centers and professional dealers servicing the new
residential, repair and remodel, and commercial construction
end-markets. The Company currently operates a network in
North America of 86 facilities in
the United States and Canada. HDI's common shares are listed on the
Toronto Stock Exchange under the symbol HDI.
Non-GAAP Measures - EBITDA
References to "EBITDA" are to earnings before interest, income
taxes, depreciation and amortization, where interest is defined as
net finance costs as per the consolidated statement of
comprehensive income. Furthermore, this press release
references certain EBITDA Ratios, such as EBITDA margin (being
EBITDA as a percentage of revenues). In addition to profit,
HDI considers EBITDA and EBITDA Ratios to be useful supplemental
measures of the Company's ability to meet debt service and capital
expenditure requirements, and interprets trends in EBITDA and
EBITDA Ratios as an indicator of relative operating
performance.
References to "Adjusted EBITDA" are EBITDA as defined above,
before certain items related to business acquisition activities.
"Adjusted EBITDA margin" is as defined above, before certain items
related to business acquisition activities, mark-to-market
adjustments, and revaluation of deferred tax assets. References to
"Adjusted profit", "Adjusted basic profit per share", and "Adjusted
diluted profit per share" are profit for the period, basic profit
per share, and diluted profit per share, before certain items
related to business acquisition activities, mark-to-market
adjustments, and revaluation of deferred tax assets. The
aforementioned adjusted measures are collectively referenced as
"the Adjusted Measures". HDI considers the Adjusted Measures to be
useful supplemental measures of the Company's profitability, its
ability to meet debt service and capital expenditure requirements,
and as an indicator of relative operating performance, before
considering the impact of business acquisition activities.
EBITDA, EBITDA Ratios, and the Adjusted Measures (collectively
"the Non-GAAP Measures") are not measures recognized by
International Financial Reporting Standards ("IFRS") and do not
have a standardized meaning prescribed by IFRS. Investors are
cautioned that the Non-GAAP Measures should not replace profit,
earnings per share or cash flows (as determined in accordance with
IFRS) as an indicator of our performance. HDI's method of
calculating the Non-GAAP Measures may differ from the methods used
by other issuers. Therefore, Non-GAAP Measures may not be
comparable to similar measures presented by other issuers.
Forward-Looking Statements
CAUTIONARY STATEMENT REGARDING FORWARD LOOKING INFORMATION
This news release includes forward-looking statements. These
involve known and unknown risks, uncertainties and other factors
that may cause actual results, performance or achievements or
industry results to be materially different from any future
results, performance or achievements expressed or implied by such
forward-looking statements. These forward-looking statements are
identified by the use of terms and phrases such as "anticipate",
"believe", "estimate", "expect", "may", "plan", "will", and similar
terms and phrases, including references to assumptions.
Forward-looking information is included, but not limited to,
information included under the headings "Second Quarter
Highlights", "Outlook", "Results of Operations for the Three Months
Ended September 30, 2022", and
"Results of Operations for the Nine Months Ended September 30, 2022."
These forward-looking statements reflect current expectations of
management regarding future events and operating performance as of
the date of this news release. Forward-looking statements involve
significant risks and uncertainties, should not be read as
guarantees of future performance or results, and will not
necessarily be accurate indications of whether or not such results
will be achieved. A number of factors could cause actual results to
differ materially from the results discussed in the forward-looking
statements, including, but not limited to: it is difficult to
reliably measure the potential impact of this uncertainty caused by
the COVID-19 pandemic on our future financial results and the
impacts to our Company are not determinable at the date of these
financial statements, however they could be material and include
impairments of receivables, inventory and reduction in available
liquidity; given the uncertainty around the potential impact of
COVID-19, this may impact our estimates disclosed in the
consolidated financial statements given that there is significant
judgment and estimation uncertainty; our results are dependent upon
the general state of the economy and downturns in the economy
(including inflation and rising interest rates), natural disasters,
disease outbreaks, terrorist activities, or threats or acts of
armed conflict (including the conflict between Russia and Ukraine), could have a negative impact on our
business, financial condition, and results of operations; decreases
in the supply of, demand for, or market values of our products
could harm our business; our products may be subject to negative
trade outcomes; we may not be able to sustain our level of sales or
EBITDA margins; competition in our markets may lead to reduced
revenues and profitability; we may become subject to more stringent
regulations; we are dependent upon our management information
systems; our insurance may be insufficient to cover losses that may
occur as a result of our operations; we are dependent upon the
financial condition and results of operations of our business; our
credit facilities affect our liquidity, contain restrictions on our
ability to borrow funds, and impose restrictions on distributions
that can be made by our operating limited partnerships; and, other
risks described in our Annual Information Form our Information
Circular and in the MD&A.
Although the forward-looking statements contained in this news
release are based upon what management believes to be reasonable
assumptions, management cannot assure investors that actual results
will be consistent with these forward-looking statements. The
forward-looking statements reflect management's current beliefs and
are based on information currently available.
All forward-looking information in this news release is
qualified in its entirety by this cautionary statement and, except
as may be required by law, HDI undertakes no obligation to revise
or update any forward-looking information as a result of new
information, future events or otherwise after the date
hereof.
SOURCE Hardwoods Distribution Inc.